The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Eptinezumab
Australian Public Assessment Report
Device/Product Name
Vyepti
Active ingredients
Eptinezumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-01823-1-1
Submission Type
New biological entity
Decision
Approved